Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors

author
created [InstanceEdit:9728224] Jassal, Bijay, 2021-04-20
dbId 9728167
displayName Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
journal Diabetes Obes Metab
pages 83-90
pubMedIdentifier 21985634
schemaClass LiteratureReference
title Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
url http://www.ncbi.nlm.nih.gov/pubmed/21985634
volume 14
year 2012
Cite Us!